相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
Florence C. Guibal et al.
BLOOD (2009)
PML-RARα initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors
S. Wojiski et al.
LEUKEMIA (2009)
The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
Gerlincle Wernig et al.
BLOOD (2008)
Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin
Samik Basu et al.
JOURNAL OF IMMUNOLOGY (2008)
Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene
Ji-Long Chen et al.
BLOOD (2008)
Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation
S. Agrawal et al.
LEUKEMIA (2008)
New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas
Christian Hallermann et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL
M Adam et al.
CANCER RESEARCH (2006)
Pim-2 upregulation: Biological implications associated with disease progression and perinueral invasion in prostate cancer
H Dai et al.
PROSTATE (2005)
Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARα
MJ Walter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival
PS Hammerman et al.
BLOOD (2005)
Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma
AM Cohen et al.
LEUKEMIA & LYMPHOMA (2004)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets
C Müller-Tidow et al.
CLINICAL CANCER RESEARCH (2004)
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors
H Mikkers et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death
B Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expression
P Westervelt et al.
BLOOD (2003)
Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia
MM Le Beau et al.
BLOOD (2003)
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
CJ Fox et al.
GENES & DEVELOPMENT (2003)
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations
M Mizuki et al.
BLOOD (2003)
Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genornics
T Kitamura et al.
EXPERIMENTAL HEMATOLOGY (2003)
PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model
LM Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia
MM Le Beau et al.
BLOOD (2002)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
PD Kottaridis et al.
BLOOD (2001)
Mouse models of acute promyelocytic leukemia
JL Pollock et al.
CURRENT OPINION IN HEMATOLOGY (2001)
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Y Yamamoto et al.
BLOOD (2001)
Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia
PP Pandolfi
HUMAN MOLECULAR GENETICS (2001)
Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice
DB Zimonjic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Two critical hits for promyelocytic leukemia
LZ He et al.
MOLECULAR CELL (2000)